Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
featured
Do You Have Osteoporosis?

Do You Have Osteoporosis?

  • 1122 views
  • 08 Nov, 2020
  • 1 location
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone

This trial is intended to test the efficacy of an oral bisphosphonate (risedronate) to decrease bone pain and improve radiological aspect in fibrous dysplasia of bone.

  • 24 views
  • 07 Nov, 2020
  • 6 locations
Osteonecrosis of the Hip and Bisphosphonate Treatment

Osteonecrosis of the hip is an important cause of musculoskeletal disability and finding therapeutic solutions has proven to be challenging. Osteonecrosis means death of bone which can occur from the loss of the blood supply or some other means. Although any age group may develop osteonecrosis, most patients are between …

hypertension
bisphosphonate
arco
steroid treatment
collapse
  • 17 views
  • 07 Nov, 2020
  • 5 locations
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

The purpose of the clinical study is to investigate whether the local delivery of bisphosphonate as a surgical adjuvant can decrease the chance of a giant cell tumor of bone coming back to the

  • 0 views
  • 15 Jan, 2021
  • 1 location
Trochanteric Femur Fracture Operated With Dynamic Hip Screw System (DHS) Augmented With a Biphasic Apatite Sulphate Combined With Systemic or Local Bisphosphonate

bisphosphonate (Zometa) locally or systemically that affects bone metabolism. Furthermore, fracture healing and implant migration will be investigated.

  • 0 views
  • 01 Jan, 2021
  • 1 location
Fosamax for Childhood Cancer Survivors

safety of bisphosphonates for treating osteoporosis in long-term cancer survivors have not been tested. The investigators hypothesize that alendronate, an orally active bisphosphonate, is

bisphosphonate
cancer
osteopenia
fosamax
alendronate
  • 6 views
  • 07 Nov, 2020
  • 1 location
Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

oral bisphosphonate alendronate can limit loss of bone mineral density associated with initiation of ART in HIV-1 infected, antiretroviral naive, adult subjects.

  • 10 views
  • 23 Jan, 2021
  • 2 locations
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas

This study evaluates the combination of lenvatinib with denosumab in bone-predominant metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas. All patients will receive this combination of treatments.

  • 0 views
  • 07 May, 2020
  • 2 locations
Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma

Osteoid osteoma (OO) is a benign osteogenic tumor occurring in children and young adults, responsible for intense bone pain, which has a tendency to spontaneously heal with mineralization of the nidus, but extremely slowly. This healing may be accelerated in patients taking NSAIDs regularly during a few years. The long …

  • 0 views
  • 16 Nov, 2020
  • 11 locations
Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

RATIONALE: Zoledronic acid may help decrease the risk of broken bones, bone pain, and other symptoms caused by bone metastases. It may also help patients live more comfortably. PURPOSE: This randomized clinical trial is studying different schedules of zoledronic acid to compare how well they work in treating patients with …

bone pain
bisphosphonate
combination therapy
metastasis
bone metastases
  • 124 views
  • 07 Nov, 2020
  • 1 location